Cargando…

Repositioning: the fast track to new anti-malarial medicines?

BACKGROUND: Repositioning of existing drugs has been suggested as a fast track for developing new anti-malarial agents. The compound libraries of GlaxoSmithKline (GSK), Pfizer and AstraZeneca (AZ) comprising drugs that have undergone clinical studies in other therapeutic areas, but not achieved appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lotharius, Julie, Gamo-Benito, Francisco Javier, Angulo-Barturen, Iñigo, Clark, Julie, Connelly, Michele, Ferrer-Bazaga, Santiago, Parkinson, Tanya, Viswanath, Pavithra, Bandodkar, Balachandra, Rautela, Nikhil, Bharath, Sowmya, Duffy, Sandra, Avery, Vicky M, Möhrle, Jörg J, Guy, R Kiplin, Wells, Timothy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021201/ https://www.ncbi.nlm.nih.gov/pubmed/24731288 http://dx.doi.org/10.1186/1475-2875-13-143

Ejemplares similares

Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay
por: Linares, María, et al.
Publicado: (2015)

Using Cryopreserved Plasmodium falciparum Sporozoites in a Humanized Mouse Model to Study Early Malaria Infection Processes and Test Prophylactic Treatments
por: Jiménez-Díaz, María-Belén, et al.
Publicado: (2023)

Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis
por: Voak, Andrew A., et al.
Publicado: (2021)

Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds
por: Ortiz, Diana, et al.
Publicado: (2015)

Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development
por: Zaloumis, Sophie, et al.
Publicado: (2012)

Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate
por: Matthews, Holly, et al.
Publicado: (2013)

Development and Optimization of a Novel 384-Well Anti-Malarial Imaging Assay Validated for High-Throughput Screening
por: Duffy, Sandra, et al.
Publicado: (2012)

Systems Analysis of Chaperone Networks in the Malarial Parasite Plasmodium falciparum
por: Pavithra, Soundara Raghavan, et al.
Publicado: (2007)

Plasmodium falciparum in vitro continuous culture conditions: A comparison of parasite susceptibility and tolerance to anti-malarial drugs throughout the asexual intra-erythrocytic life cycle
por: Duffy, Sandra, et al.
Publicado: (2017)

A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission
por: Baker, David A., et al.
Publicado: (2017)

A novel class of fast‐acting antimalarial agents: Substituted 15‐membered azalides
por: Peric, Mihaela, et al.
Publicado: (2020)

New developments in anti-malarial target candidate and product profiles
por: Burrows, Jeremy N., et al.
Publicado: (2017)

Erratum to: New developments in anti-malarial target candidate and product profiles
por: Burrows, Jeremy N., et al.
Publicado: (2017)

Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones
por: Chen, Yizhe, et al.
Publicado: (2021)

Is "Malarial Cachexia" Purely Malarial?
por: Rogers, Leonard
Publicado: (1902)

Malarial Fevers and Malarial Parasites
Publicado: (1903)

The multistate tuberculosis pharmacometric model: a semi-mechanistic pharmacokinetic-pharmacodynamic model for studying drug effects in an acute tuberculosis mouse model
por: Chen, Chunli, et al.
Publicado: (2017)

Comparison of coronally advanced versus semilunar coronally repositioned flap in the management of maxillary gingival recessions
por: Govindasamy, Bharath R., et al.
Publicado: (2021)

A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents
por: Bahamontes-Rosa, Noemí, et al.
Publicado: (2016)

Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria
por: Macintyre, Fiona, et al.
Publicado: (2018)

Lip repositioning
por: Gaddale, Reetika, et al.
Publicado: (2014)

Acute Malarial Toxæmia, and the Pathology of Diseases of Malarial Origin
Publicado: (1870)

Drug Repositioning as a Therapeutic Strategy against Streptococcus pneumoniae: Cell Membrane as Potential Target
por: Ortiz-Miravalles, Laura, et al.
Publicado: (2023)

Towards optimal design of anti-malarial pharmacokinetic studies
por: Simpson, Julie A, et al.
Publicado: (2009)

Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice
por: SheelaNair, Arya, et al.
Publicado: (2022)

Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
por: McCarthy, James S, et al.
Publicado: (2017)

MALARIAL PARASITOLOGY
por: Ewing, James
Publicado: (1901)

Malarial Fevers
por: O'Connell, M. D.
Publicado: (1891)

Malarial Fevers
por: Hall, G. C., et al.
Publicado: (1891)

Malarial Analogies
por: Roberts, J. R.
Publicado: (1891)

Malarial Gangrene
por: Hammond, F. A. L.
Publicado: (1913)

Malarial Pneumonia
por: Paterson, J. Fergus
Publicado: (1908)

Malarious Hæmophilia
Publicado: (1890)

The Malarial Parasite
por: Walsh, J. H. Tull
Publicado: (1897)

On Malarious Urticaria
por: Neve, A.
Publicado: (1883)

Malarial Pigmentation
por: Sen, H.
Publicado: (1900)

Malarial Cachexy
por: Slane, J.
Publicado: (1883)

Malarial Apoplexy
por: Fearnside, C. J.
Publicado: (1899)

Malarial Melanmia
por: Hehir, Patrick
Publicado: (1894)

Malarial Melanæmia
por: Hehir, Patrick
Publicado: (1894)

Cannot write session to /tmp/vufind_sessions/sess_c5j57t7vr7kssff06csq63jd20